TNG Pharmaceuticals' Series A Round

TNG Pharmaceuticals raised a round of funding on February 07, 2014.

TNG Pharmaceuticals is furthering the development of a patented vaccine, FlyVax. FlyVax is a veterinary vaccine that is expected to inhibit the horn fly's ability to effectively feed on cattle. FlyVax…

Articles about TNG Pharmaceuticals' Series A Round: